Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02919059
What this trial is testing

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

Who this might be right for
Diabetes Mellitus, Type 2
IInstituto Gallego de Medicina Vascular 159
Not applicableStudy completedNCT04416841
What this trial is testing

Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 2Cognitive Dysfunction
Jing Tao 328
Large-scale testing (Phase 3)Study completedNCT01177813
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 986
Not applicableStudy completedNCT03680482
What this trial is testing

To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
University of Chile 17
Large-scale testing (Phase 3)Study completedNCT01031680
What this trial is testing

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

Who this might be right for
Type 2 Diabetes MellitusCardiovascular DiseaseHypertension+1 more
AstraZeneca 922
Not applicableStudy completedNCT05417646
What this trial is testing

Impact of SGLT2 on Glucosuria in HNF1A-MODY

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3Type 2 Diabetes
Steno Diabetes Center Copenhagen 21
Not applicableStudy completedNCT04114903
What this trial is testing

Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

Who this might be right for
Type 2 DiabetesObesityCannabis Use+1 more
University of Colorado, Boulder 233
Not applicableStudy completedNCT05034380
What this trial is testing

Epigenetic Effects of a Single Bout of Exercise on Cardiovascular Risk Factors and the Metabolome

Who this might be right for
ObesityType 2 DiabetesCardiovascular Diseases+1 more
East Carolina University 30
Large-scale testing (Phase 3)Study completedNCT06418880
What this trial is testing

Automated Insulin Delivery for Inpatients With Dysglycemia

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Emory University 130
Not applicableNot Yet RecruitingNCT06732362
What this trial is testing

To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading

Who this might be right for
Diabetes Mellitus, Type 2
Zheng Guo 60
Testing effectiveness (Phase 2)Looking for participantsNCT06937203
What this trial is testing

A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Arrowhead Pharmaceuticals 150
Large-scale testing (Phase 3)Ended earlyNCT00267683
What this trial is testing

Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9
Post-approval studies (Phase 4)UnknownNCT05597202
What this trial is testing

Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22
Not applicableStudy completedNCT00784745
What this trial is testing

Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect

Who this might be right for
Insulin ResistanceGlucose Intolerance
University Hospital, Gentofte, Copenhagen 21
Not applicableStudy completedNCT01995539
What this trial is testing

Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India

Who this might be right for
Diabetes Mellitus, Type 2
Medtronic MiniMed, Inc. 181
Post-approval studies (Phase 4)UnknownNCT03320031
What this trial is testing

Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy

Who this might be right for
Type 2 Diabetes MellitusPeritoneal Dialysis
Yanbing Li 232
Not applicableEnrolling By InvitationNCT07422831
What this trial is testing

T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking

Who this might be right for
Type 2 DiabetesNon Insulin Dependent Diabetes
University of Colorado, Denver 188
Not applicableStudy completedNCT03222245
What this trial is testing

The Effect of Injectable Therapies on Quality of Life in Diabetes

Who this might be right for
Diabetes
Portsmouth Hospitals NHS Trust 256
Not applicableStudy completedNCT00142701
What this trial is testing

Enhancing Support for Women at Risk for Heart Disease

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCoronary Disease+2 more
Oregon Research Institute
Not applicableUnknownNCT03622957
What this trial is testing

Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2AlbuminuriaCardiovascular Risk Factor
University of Pisa 200
Next Page